CoreWeave Director Michael Intrator Files to Sell $14.6M in Stock Amid Heavy Insider Selling
CRWV sits 28% above its 52-week low of $63.8.
Summary
CoreWeave director and officer Michael Intrator plans to sell an additional $14.6 million in stock under a 10b5-1 plan, adding to $409.7 million in insider sales over the past three months.
Key Events · Ownership and Investor Activity · CRWV
-
Insider Files to Sell $14.6M
Director and Officer Michael Intrator filed a Form 144 to sell 200,000 shares worth approximately $14.6 million, with the sale expected on or after July 21, 2026.
-
Part of 10b5-1 Trading Plan
The sale is executed under a pre-arranged 10b5-1 trading plan adopted on November 20, 2025, indicating the transaction was planned in advance.
-
Heavy Insider Selling Pattern
Over the past three months, Intrator and his affiliated entity Omnadora Capital LLC have sold 3,944,929 shares for gross proceeds of $409.7 million, reflecting a sustained distribution trend.
-
Context of High Capital Needs
CoreWeave recently reported a $740 million net loss in Q1 2026 and secured a $3.1 billion loan facility to fund GPU infrastructure, highlighting significant cash requirements amid the insider selling.
Analysis · CRWV · Technology
Michael Intrator, a director and officer of CoreWeave, has filed a Form 144 to sell 200,000 shares worth approximately $14.6 million. This sale is part of a pre-existing 10b5-1 trading plan adopted in November 2025. Over the past three months, Intrator and his affiliated entity, Omnadora Capital LLC, have already sold nearly 4 million shares for gross proceeds of $409.7 million. While the sale is planned and not necessarily a signal of immediate concern, the sheer volume of insider selling — over $400 million in three months — is a significant distribution event that warrants investor attention, especially given the company's high capital expenditure needs and recent stock price volatility.
At the time of this filing, CRWV was trading at $81.75 on NASDAQ in the Technology sector, with a market capitalization of approximately $43.4B. The 52-week trading range was $63.80 to $153.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.